Related Experiment Video
Updated: Jul 7, 2026

A Novel Method for Involving Women of Color at High Risk for Preterm Birth in Research Priority Setting
Published on: January 12, 2018
Medically indicated preterm birth: recognizing the importance of the problem
Cande V Ananth1, Anthony M Vintzileos
1Division of Epidemiology and Biostatistics, Department of Obstetrics, Gynecology, and Reproductive Sciences, UMDNJ-Robert Wood Johnson Medical School, New Brunswick, NJ 08901-1977, USA. cande.ananth@umdnj.edu
Insights
Preterm birth, especially medically indicated, is rising. Ischemic placental disease is a key factor, highlighting the need to evaluate risk factors for prediction and prevention.
Area of Science:
- Obstetrics and Gynecology
- Perinatal Medicine
- Reproductive Health
Background:
- Preterm birth (<37 weeks) affects over 500,000 US births annually, with a notable increase in medically indicated preterm births.
- Medically indicated preterm births are often prompted by maternal/fetal conditions like preeclampsia, intrauterine growth restriction, and placental abruption, collectively termed "ischemic placental disease."
Purpose of the Study:
- To investigate the role of ischemic placental disease in medically indicated preterm births.
- To explore the heterogeneity of medically indicated preterm birth and ischemic placental disease for improved prediction and prevention strategies.
Main Methods:
- Review of temporal trends in preterm birth rates.
- Analysis of the association between ischemic placental disease and indicated preterm birth versus term birth.
- Consideration of risk factors and syndrome heterogeneity.
Main Results:
- Ischemic placental disease is implicated in over half of indicated preterm births, significantly more than term births.
- A temporal increase in medically indicated preterm birth parallels the rise in preterm birth rates.
- Understanding the diverse factors within medically indicated preterm birth and ischemic placental disease is crucial.
Conclusions:
- Ischemic placental disease is a significant contributor to medically indicated preterm birth.
- Further evaluation of risk factors and syndrome heterogeneity is essential for predicting and preventing preterm birth.
Abstract:
Preterm birth complicates over 500,000 births annually, affecting 12.5% of pregnancies in the United States. Much of the temporal increase in preterm birth (<37 weeks) over the past decade is largely driven by a concurrent temporal increase in medically indicated preterm birth. Maternal and fetal indications that prompt an intervention at preterm gestational ages include preeclampsia, intrauterine growth restriction, and placental abruption-conditions that constitute "ischemic placental disease." Ischemic placental disease is implicated in over one of every two indicated preterm births compared with less than one in five births at term. Comprehensive evaluation of risk factors, with careful consideration of heterogeneity in the syndrome of medically indicated preterm birth and ischemic placental disease may provide important clues to predict and consequently prevent preterm birth.
Related Concept Videos
Mitral Valve Prolapse III: Nursing Management
Nursing Diagnosis
The nursing diagnosis focuses on evidence-based...
Diabetes Mellitus: Type 2 and Gestational
Pre-Procedural Guidelines for Assessing Blood Pressure
Preventive Healthcare Services
Regression Toward the Mean

